Get started
Author

Yumiko Shiraki

Observed name: YUMIKO SHIRAKI
OpenAlex ID: A5111573733
Vitamin K2 (Menatetrenone) Effectively Prevents Fractures and Sustains Lumbar Bone Mineral Density in Osteoporosis
2000 · Masataka Shiraki, Yumiko Shiraki, et al. · Journal of Bone and Mineral Research · 409
Association of Bone Mineral Density with Apolipoprotein E Phenotype
1997 · Masataka Shiraki, Yumiko Shiraki, et al. · Journal of Bone and Mineral Research · 196
Urinary pentosidine and plasma homocysteine levels at baseline predict future fractures in osteoporosis patients under bisphosphonate treatment
2010 · Masataka Shiraki, Tatsuhiko Kuroda, et al. · Journal of Bone and Mineral Metabolism · 56
Serum 25-hydroxyvitamin D below 25 ng/mL is a risk factor for long bone fracture comparable to bone mineral density in Japanese postmenopausal women
2013 · Shiro Tanaka, Tatsuhiko Kuroda, et al. · Journal of Bone and Mineral Metabolism · 53
High level of serum undercarboxylated osteocalcin in patients with incident fractures during bisphosphonate treatment
2010 · Masataka Shiraki, Yasushi Yamazaki, et al. · Journal of Bone and Mineral Metabolism · 40
Plasma Level of Homocysteine Associated with Severe Vertebral Fracture in Postmenopausal Women
2013 · Tatsuhiko Kuroda, Shiro Tanaka, et al. · Calcified Tissue International · 34
The Relationship Between Back Pain and Future Vertebral Fracture in Postmenopausal Women
2009 · Tatsuhiko Kuroda, Masataka Shiraki, et al. · Spine · 23
The Importance of Absolute Bone Mineral Density in the Assessment of Antiresorptive Agents Used for the Prevention of Osteoporotic Fractures
2012 · Tatsuhiko Kuroda, Masataka Shiraki, et al. · Journal of Clinical Densitometry · 10
Effect of 1 .ALPHA.-Hydroxyvitamin D3 on Loss of Bone Mineral Density Immediately after Artificial Menopause.
1997 · TOMOYASU KATO, JUI-TUNG CHEN, et al. · Endocrine Journal · 5
PDF
Works count: 9
Citation count: 826
H-index: 8
I10-index: 8
Year
Topic
Type